- We will send in 10–14 business days.
/images/books/12405411/9781849733625.jpg)
- Publisher: Royal Society of Chemistry
- Year: 2012
- Pages: 394
- ISBN-10: 1849733627
- ISBN-13: 9781849733625
- Format: 16.1 x 23.8 x 2.7 cm, hardcover
- Language: English
- SAVE -10% with code: EXTRA
Designing Multi-Target Drugs (e-book) (used book) | bookbook.eu
Reviews
Description
Multi-target drug discovery (MTDD) is an emerging area of increasing interest to the drug discovery community. Drugs that modulate several targets have the potential for an improved balance of efficacy and safety compared to single targets agents. Although there are a number of marketed drugs that are thought to derive their therapeutic benefit by virtue of interacting with multiple targets, the majority of these were discovered accidentally. Written by world renowned experts, this is the first book to gather together knowledge and experiences of the rational discovery of multi-target drugs. It describes the current state of the art, the achievements and the challenges of the field and importantly the lessons learned by researchers to date and their application to future MTDD.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 19d.23:33:40
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Royal Society of Chemistry
- Year: 2012
- Pages: 394
- ISBN-10: 1849733627
- ISBN-13: 9781849733625
- Format: 16.1 x 23.8 x 2.7 cm, hardcover
- Language: English English
Multi-target drug discovery (MTDD) is an emerging area of increasing interest to the drug discovery community. Drugs that modulate several targets have the potential for an improved balance of efficacy and safety compared to single targets agents. Although there are a number of marketed drugs that are thought to derive their therapeutic benefit by virtue of interacting with multiple targets, the majority of these were discovered accidentally. Written by world renowned experts, this is the first book to gather together knowledge and experiences of the rational discovery of multi-target drugs. It describes the current state of the art, the achievements and the challenges of the field and importantly the lessons learned by researchers to date and their application to future MTDD.
Reviews